Épidémie de nouveau variant de la maladie de Creutzfeldt-Jakob au Royaume-Uni : anatomie et physiologie des modèles prédictifs

Annick Alpérovitch; Jérôme Huillard d’Aignaux

doi:10.1051/medsci/200218111081

Home

All issues

Volume 18 / No 11 (Novembre 2002)

Med Sci (Paris), 18 11 (2002) 1081-1088

References

Free Access

Issue		Med Sci (Paris) Volume 18, Number 11, Novembre 2002


Page(s)		1081 - 1088
Section		M/S Revues : Articles de Synthèse
DOI		https://doi.org/10.1051/medsci/200218111081
Published online		15 November 2002

Will RG, Ironside JW, Zeidler M, et al. A new variant Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921–5. [Google Scholar]
Chazot G, Broussolle E, Lapras C, Blättler T, Aguzzi A, Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996; 347: 1181–8. [Google Scholar]
Bruce M, Will RG, Ironside JW, et al. Transmissions to mice indicate that ’new variant’ CJD is caused by the BSE agent. Nature 1997; 389: 498–501. [Google Scholar]
Lasmézas CI, Deslys JP, Demalmay R, et al. BSE transmission to macaques. Nature 1996; 381: 743–4. [Google Scholar]
Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448–50. [Google Scholar]
Gore SM, Bingham S, Day NE. Age related dietary exposure to meat products from dietary surveys of teenagers and adults in the 1980s and 1990s. Br Med J 1997; 315: 404–5. [Google Scholar]
Cousens S, Smith PG, Ward H, et al. Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet 2001; 357: 1002–7. [Google Scholar]
Bryant G, Monk P. Summary of the final report of the investigation in the North Leicesterhire cluster of variant Creutzfeldt-Jakob disease. Leicestershire NHS Health Authority, 2001. http://www.leics-ha.org.uk (consulté le 7 octobre 2002). [Google Scholar]
Andrews NJ, Farrington CP, Cousens SN, et al. Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet 2000; 356: 481–2. [Google Scholar]
The EuroCJD Group. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. Rev Neurol (Paris) 2001; 157: 633–7. [Google Scholar]
Huillard d’Aignaux J, Costagliola D, Maccario J, et al. Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999; 53: 1197–201. [Google Scholar]
Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG. Predicting the CJD epidemic in humans. Nature 1997; 385: 197–8. [Google Scholar]
Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted vCJD mortality in Great Britain. Nature 2000; 406: 583–4. [Google Scholar]
Huillard d’Aignaux J, Cousens SN, Smith PG. Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 2001; 294: 1729–31. [Google Scholar]
Valleron AJ, Boelle PY, Will RG, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294: 1726–8. [Google Scholar]
Ferguson NM, Ghani AC, Donnelly CA, Hagenaars TJ, Anderson RM. Estimating the human health risk from possible BSE infection of the British sheep flock. Nature 2002; 415: 420–4. [Google Scholar]
Cooper JD, Bird SM, De Angelis D. Prevalence of detectable abnormal prion protein in persons incubating vCJD: plausible incubation periods and cautious inference. J Epidemiol Biostat 2000; 5: 209–19. [Google Scholar]
Ghani AC, Ferguson NM, Donnelly CA, Hanegaars TJ, Anderson RM. Estimating the number of people incubating variant CJD. Lancet 1998; 352: 1353–4. [Google Scholar]
Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183–9. [Google Scholar]
Ironside JW, Hilton DA, Ghani AC, et al. Retrospectivestudy of prion-protein accumulation in tonsil and appendix tissues. Lancet 2000; 355: 1693–4. [Google Scholar]
Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991; 253: 37–42. [Google Scholar]
Huillard d’Aignaux J, Cousens SN, Maccario J, et al. An analysis of the incubation period of kuru by sex and age at infection. Epidemiology 2002 (sous presse). [Google Scholar]
Lloyd SE, Onwuazor ON, Beck JA, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 2001; 98: 6279–83. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.

[1] Will RG, Ironside JW, Zeidler M, et al. A new variant Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921–5. [Google Scholar]

[2] Chazot G, Broussolle E, Lapras C, Blättler T, Aguzzi A, Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996; 347: 1181–8. [Google Scholar]

[3] Bruce M, Will RG, Ironside JW, et al. Transmissions to mice indicate that ’new variant’ CJD is caused by the BSE agent. Nature 1997; 389: 498–501. [Google Scholar]

[4] Lasmézas CI, Deslys JP, Demalmay R, et al. BSE transmission to macaques. Nature 1996; 381: 743–4. [Google Scholar]

[5] Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448–50. [Google Scholar]

[6] Gore SM, Bingham S, Day NE. Age related dietary exposure to meat products from dietary surveys of teenagers and adults in the 1980s and 1990s. Br Med J 1997; 315: 404–5. [Google Scholar]

[7] Cousens S, Smith PG, Ward H, et al. Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet 2001; 357: 1002–7. [Google Scholar]

[8] Bryant G, Monk P. Summary of the final report of the investigation in the North Leicesterhire cluster of variant Creutzfeldt-Jakob disease. Leicestershire NHS Health Authority, 2001. http://www.leics-ha.org.uk (consulté le 7 octobre 2002). [Google Scholar]

[9] Andrews NJ, Farrington CP, Cousens SN, et al. Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet 2000; 356: 481–2. [Google Scholar]

[10] The EuroCJD Group. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. Rev Neurol (Paris) 2001; 157: 633–7. [Google Scholar]

[11] Huillard d’Aignaux J, Costagliola D, Maccario J, et al. Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999; 53: 1197–201. [Google Scholar]

[12] Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG. Predicting the CJD epidemic in humans. Nature 1997; 385: 197–8. [Google Scholar]

[13] Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted vCJD mortality in Great Britain. Nature 2000; 406: 583–4. [Google Scholar]

[14] Huillard d’Aignaux J, Cousens SN, Smith PG. Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 2001; 294: 1729–31. [Google Scholar]

[15] Valleron AJ, Boelle PY, Will RG, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294: 1726–8. [Google Scholar]

[16] Ferguson NM, Ghani AC, Donnelly CA, Hagenaars TJ, Anderson RM. Estimating the human health risk from possible BSE infection of the British sheep flock. Nature 2002; 415: 420–4. [Google Scholar]

[17] Cooper JD, Bird SM, De Angelis D. Prevalence of detectable abnormal prion protein in persons incubating vCJD: plausible incubation periods and cautious inference. J Epidemiol Biostat 2000; 5: 209–19. [Google Scholar]

[18] Ghani AC, Ferguson NM, Donnelly CA, Hanegaars TJ, Anderson RM. Estimating the number of people incubating variant CJD. Lancet 1998; 352: 1353–4. [Google Scholar]

[19] Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183–9. [Google Scholar]

[20] Ironside JW, Hilton DA, Ghani AC, et al. Retrospectivestudy of prion-protein accumulation in tonsil and appendix tissues. Lancet 2000; 355: 1693–4. [Google Scholar]

[21] Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991; 253: 37–42. [Google Scholar]

[22] Huillard d’Aignaux J, Cousens SN, Maccario J, et al. An analysis of the incubation period of kuru by sex and age at infection. Epidemiology 2002 (sous presse). [Google Scholar]

[23] Lloyd SE, Onwuazor ON, Beck JA, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 2001; 98: 6279–83. [Google Scholar]